Amit Kalra | ASH 2018 | Early prediction of chronic GvHD
ASH 2018 | Prediction of severe chronic graft-versus-host disease by host-derived CXCR3 ligand genes
Severe cGvHD could be predicted both by a genetic risk group of four SNPs in recipients’ CXCR3 ligand genes and by serum CXCL9 levels 28 days after...
ASH 2018 | Pharmacodynamics and updated data from the phase IIa KD025-208 trial
A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics and Updated Results.
Subscribe to get the best content related to GvHD delivered to your inbox